Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Iradimed Corp (IRMD)

Iradimed Corp (IRMD)
52.29 +2.19 (+4.37%) 04/11/25 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime 52.29 unch (unch) 04/11/25
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
49.28
Day High
52.53
Open 50.50
Previous Close 50.10 50.10
Volume 57,700 57,700
Avg Vol 37,605 37,605
Stochastic %K 58.98% 58.98%
Weighted Alpha +20.89 +20.89
5-Day Change +2.37 (+4.75%) +2.37 (+4.75%)
52-Week Range 40.18 - 63.29 40.18 - 63.29
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 664,867
  • Shares Outstanding, K 12,715
  • Annual Sales, $ 73,240 K
  • Annual Income, $ 19,230 K
  • EBIT $ 22 M
  • EBITDA $ 23 M
  • 60-Month Beta 0.82
  • Price/Sales 8.70
  • Price/Cash Flow 31.67
  • Price/Book 7.31

Options Overview Details

View History
  • Implied Volatility 49.58% ( -3.74%)
  • Historical Volatility 32.35%
  • IV Percentile 81%
  • IV Rank 69.41%
  • IV High 63.78% on 07/05/24
  • IV Low 17.34% on 05/20/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 162
  • Open Int (30-Day) 156

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.40
  • Number of Estimates 1
  • High Estimate 0.40
  • Low Estimate 0.40
  • Prior Year 0.32
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.48 +10.14%
on 04/09/25
Period Open: 52.31
54.10 -3.35%
on 04/01/25
-0.02 (-0.04%)
since 03/11/25
3-Month
47.48 +10.14%
on 04/09/25
Period Open: 56.59
63.29 -17.38%
on 02/05/25
-4.30 (-7.60%)
since 01/10/25
52-Week
40.18 +30.14%
on 04/19/24
Period Open: 41.99
63.29 -17.38%
on 02/05/25
+10.30 (+24.53%)
since 04/11/24

Most Recent Stories

More News
IRADIMED CORPORATION To Participate at the 37th Annual Roth Conference

IRMD : 52.29 (+4.37%)
IRadimed: Q4 Earnings Snapshot

IRadimed: Q4 Earnings Snapshot

IRMD : 52.29 (+4.37%)
IRADIMED CORPORATION Announces Fourth Quarter and Full Year of 2024 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.17 Per Share from $0.15 Per Share

IRMD : 52.29 (+4.37%)
IRADIMED CORPORATION to Hold Fourth Quarter of 2024, Full Year of 2024 Financial Results Conference Call on February 13, 2025

IRMD : 52.29 (+4.37%)
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues

IRMD : 52.29 (+4.37%)
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

IRADIMED announces CEO and CFO will present at J.P. Morgan Healthcare Conference on January 15, 2025.Quiver AI SummaryIRADIMED CORPORATION announced that CEO Roger Susi and CFO Jack Glenn will present...

IRMD : 52.29 (+4.37%)
IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare Conference

IRMD : 52.29 (+4.37%)
Iradimed Corporation Achieves 24th Place on Forbes' List of America's Most Successful Small-Cap Companies 2025

Iradimed Corporation ranked 24th on Forbes' list of America's Most Successful Small-Cap Companies for 2025, highlighting strong growth.Quiver AI SummaryIradimed Corporation, based in Winter Springs, Florida,...

IRMD : 52.29 (+4.37%)
IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025

IRMD : 52.29 (+4.37%)
Insider Sale: CHIEF FINANCIAL OFFICER of $IRMD (IRMD) Sells 2,500 Shares

JOHN GLENN, the CHIEF FINANCIAL OFFICER of $IRMD ($IRMD), sold 2,500 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 36.3%...

IRMD : 52.29 (+4.37%)

Business Summary

iRadimed Corporation engages in developing, manufacturing, marketing, and distributing magnetic resonance imaging (MRI) compatible products. It offers non-magnetic intravenous (IV) infusion pump systems, IV tubing sets, IV poles, wireless remote displays/controls under the mRidium name; side car pump...

See More

Key Turning Points

3rd Resistance Point 56.70
2nd Resistance Point 54.62
1st Resistance Point 53.45
Last Price 52.29
1st Support Level 50.20
2nd Support Level 48.12
3rd Support Level 46.95

See More

52-Week High 63.29
Fibonacci 61.8% 54.46
Last Price 52.29
Fibonacci 50% 51.74
Fibonacci 38.2% 49.01
52-Week Low 40.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar